DONNA WALKER: Open Payments
NPI 1720210651 · EUCLID, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 6 payments from 6 companies in 2025. Trend: 2023 $549 · 2024 $556 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| SCPHARMACEUTICALS INC. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $89 |
| Novartis Pharmaceuticals Corporation | 1 | $57 |
Products named: DUPIXENT, FUROSCIX, TEZSPIRE, JARDIANCE, ENTYVIO, LEQVIO.
Industry payments across OH — which companies pay providers there.
